Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers
- 24 June 2020
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 22 (7) , 1-9
Abstract
Purpose of Review We review emerging evidence regarding the impact of gut microbes on antitumor immunity, and ongoing efforts to translate this in clinical trials. Recent Findings Pre-clinical models and human cohort studies support a role for gut microbes in modulating overall immunity and immunotherapy response, and numerous trials are now underway exploring strategies to modulate gut microbes to enhance responses to cancer therapy. This includes the use of fecal microbiota transplant (FMT), which is being used to treat patients with Clostridium difficile infection among other non-cancer indications. The use of FMT is now being extended to modulate gut microbes in patients being treated with cancer immunotherapy, with the goal of enhancing responses and/or to ameliorate toxicity. However, significant complexities exist with such an approach and will be discussed herein. Summary Data from ongoing studies of FMT in cancer will provide critical insights for optimization of this approach.Keywords
This publication has 55 references indexed in Scilit:
- Dysbiosis of the gut microbiota in diseaseMicrobial Ecology in Health and Disease, 2015
- The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationBlood, 2014
- Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and ControversiesGastroenterology, 2014
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of CyclophosphamideScience, 2013
- The microbiome and cancerNature Reviews Cancer, 2013
- Duodenal Infusion of Donor Feces for RecurrentClostridium difficileNew England Journal of Medicine, 2013
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic SyndromeGastroenterology, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal FloraJournal of Clinical Gastroenterology, 2010
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006